Ameriprise’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-72,252
Closed -$940K 4061
2025
Q2
$940K Buy
72,252
+57,152
+378% +$676K ﹤0.01% 3293
2025
Q1
$160K Sell
15,100
-3,513
-19% -$55.8K ﹤0.01% 3822
2024
Q4
$316K Buy
18,613
+883
+5% +$16.6K ﹤0.01% 3701
2024
Q3
$412K Sell
17,730
-1,460
-8% -$31.2K ﹤0.01% 3554
2024
Q2
$467K Buy
19,190
+1,305
+7% +$39.6K ﹤0.01% 3439
2024
Q1
$604K Sell
17,885
-7,343
-29% -$260K ﹤0.01% 3354
2023
Q4
$795K Buy
25,228
+16,443
+187% +$391K ﹤0.01% 3286
2023
Q3
$224K Sell
8,785
-138
-2% -$4.25K ﹤0.01% 3670
2023
Q2
$256K Buy
8,923
+115
+1% +$3.13K ﹤0.01% 3653
2023
Q1
$211K Sell
8,808
-6,722
-43% -$121K ﹤0.01% 3717
2022
Q4
$263K Buy
15,530
+1,510
+11% +$26.3K ﹤0.01% 3634
2022
Q3
$208K Buy
+14,020
New +$235K ﹤0.01% 3690
2021
Q4
Sell
-5,830
Closed -$279K 3957
2021
Q3
$279K Buy
+5,830
New +$261K ﹤0.01% 3600
2021
Q1
Sell
-9,559
Closed -$415K 3836
2020
Q4
$415K Sell
9,559
-46,765
-83% -$3.17M ﹤0.01% 3407
2020
Q3
$2.42M Sell
56,324
-13,978
-20% -$694K ﹤0.01% 2559
2020
Q2
$3.29M Buy
+70,302
New +$2.42M ﹤0.01% 2346

Other funds holding ARCT